Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke "SPARCL"

Completed

Phase 4 Results

Summary of Purpose

To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 April 2015.

1 Nov 1998 6 Sep 2005 Unavailable 1 Nov 2005 1 Apr 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Henirk Sillesen, MD, DMSc, Department of Vascular Surgery, Gentofte University Hospital, DK-2900 Hellerup (Denmark). Phone 45 3977 3402. Fax 45 3977 7674. E-mail hens@gentoftehosp.kbhamt.dk

    hens@gentoftehosp.kbhamt.dk